Home » Newsletters » BioWorld Science

BioWorld Science

Dec. 1, 2006

View Archived Issues

Topical phenytoin administration may be useful for nonhealing corneal ulcers

Data on new cancer therapeutics presented at EORTC-NCI-AACR

Emergence of X4 phenotype with maraviroc investigated in HIV patients

Drug-drug interactions, other data on etravirine reported

West Nile virus vaccine candidates show promise

ALK-Abello and Menarini sign Grazax agreement

Hookworm vaccine, treatment evaluated in clinical studies

IRB approval for phase II study of DCVax-Brain in GBM

Elixir raises proceeds to support pipeline development

Norwood Immunology shareholders approve Virosome Biologicals acquisition

Positive data for Multiferon in rabbitpox virus study

Sinclair signs agreement to acquire novel anticaries peptide p1025

Sulforaphane investigated for chemoprevention

Genzyme acquires option for NsGene's neurotrophic factor NsG-33

SB-509 begins phase II study for diabetic neuropathy

Cetrorelix set to begin phase III for BPH

Abuse-resistant PTI-202 safe and well tolerated in phase I study

Genasense studied together with Abraxane and Temodar in advanced melanoma

Atu-027 RNAi more effective in prevention of metastases than gemcitabine

Boehringer Ingelheim ensures access to Viramune in developing countries

M-Vax phase III trial in metastatic melanoma cleared to begin

Interim results suggest antileukemic activity of sapacitabine

Japanese approval sought for nateglinide in combination with insulin sensitizer

Sprycel approved in E.U.

Recent patents divulge novel analgesic agents

Novel agents for treating renal and urological disorders disclosed in recent patents

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 5, 2025.
MicroRNAs in circulating extracellular vesicles as IPF biomarkers
BioWorld Science
MicroRNAs (miRNAs) are small noncoding RNAs gaining increasing attention due to their crucial role in gene expression regulation and influence in various cellular...
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Study identifies CAND1 as therapeutic target in hepatoblastoma
BioWorld Science
Hepatoblastoma is the most common liver cancer during childhood, with limited therapeutic options in aggressive or relapsed cases. NEDDylation is a...